Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.

@article{Asano2008ReducingAC,
  title={Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.},
  author={Sayaka Asano and Kensaku Miyake and Ichiro Ota and Gentaro Sugita and Wataru Kimura and Yuji Sakka and Nobuyuki Yabe},
  journal={Journal of cataract and refractive surgery},
  year={2008},
  volume={34 1},
  pages={57-63}
}
PURPOSE To compare the effectiveness of a topical nonsteroidal drug (diclofenac 0.1%) and a topical steroidal drug (betamethasone 0.1%) in preventing cystoid macular edema (CME) and blood-aqueous barrier (BAB) disruption after small-incision cataract surgery and foldable intraocular lens (IOL) implantation. SETTINGS Shohzankai Medical Foundation Miyake Eye Hospital, Tokyo, Japan. METHODS This multicenter interventional double-masked randomized study comprised 142 patients having… CONTINUE READING